Literature DB >> 20801421

Mechanisms of protein kinase A anchoring.

Philipp Skroblin1, Solveig Grossmann, Gesa Schäfer, Walter Rosenthal, Enno Klussmann.   

Abstract

The second messenger cyclic adenosine monophosphate (cAMP), which is produced by adenylyl cyclases following stimulation of G-protein-coupled receptors, exerts its effect mainly through the cAMP-dependent serine/threonine protein kinase A (PKA). Due to the ubiquitous nature of the cAMP/PKA system, PKA signaling pathways underlie strict spatial and temporal control to achieve specificity. A-kinase anchoring proteins (AKAPs) bind to the regulatory subunit dimer of the tetrameric PKA holoenzyme and thereby target PKA to defined cellular compartments in the vicinity of its substrates. AKAPs promote the termination of cAMP signals by recruiting phosphodiesterases and protein phosphatases, and the integration of signaling pathways by binding additional signaling proteins. AKAPs are a heterogeneous family of proteins that only display similarity within their PKA-binding domains, amphipathic helixes docking into a hydrophobic groove formed by the PKA regulatory subunit dimer. This review summarizes the current state of information on compartmentalized cAMP/PKA signaling with a major focus on structural aspects, evolution, diversity, and (patho)physiological functions of AKAPs and intends to outline newly emerging directions of the field, such as the elucidation of AKAP mutations and alterations of AKAP expression in human diseases, and the validation of AKAP-dependent protein-protein interactions as new drug targets. In addition, alternative PKA anchoring mechanisms employed by noncanonical AKAPs and PKA catalytic subunit-interacting proteins are illustrated. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801421     DOI: 10.1016/S1937-6448(10)83005-9

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  82 in total

Review 1.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Authors:  Thérèse Keravis; Claire Lugnier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Mitochondrial regulation of cell cycle and proliferation.

Authors:  Valeria Gabriela Antico Arciuch; María Eugenia Elguero; Juan José Poderoso; María Cecilia Carreras
Journal:  Antioxid Redox Signal       Date:  2012-01-13       Impact factor: 8.401

Review 4.  Spatial control of cAMP signalling in health and disease.

Authors:  Manuela Zaccolo
Journal:  Curr Opin Pharmacol       Date:  2011-10-13       Impact factor: 5.547

5.  Receptor-mediated Ca2+ and PKC signaling triggers the loss of cortical PKA compartmentalization through the redistribution of gravin.

Authors:  Micah B Schott; Bryon Grove
Journal:  Cell Signal       Date:  2013-07-06       Impact factor: 4.315

6.  Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa.

Authors:  Itziar Urizar-Arenaza; Nerea Osinalde; Vyacheslav Akimov; Michele Puglia; Luz Candenas; Francisco Maria Pinto; Iraia Muñoa-Hoyos; Marta Gianzo; Roberto Matorras; Jon Irazusta; Blagoy Blagoev; Nerea Subiran; Irina Kratchmarova
Journal:  Mol Cell Proteomics       Date:  2019-01-08       Impact factor: 5.911

7.  Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).

Authors:  Marie Helene Schernthaner-Reiter; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

8.  Mechanism for targeting the A-kinase anchoring protein AKAP18δ to the membrane.

Authors:  Andreas Horner; Frank Goetz; Robert Tampé; Enno Klussmann; Peter Pohl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

Review 9.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

10.  Neurochondrin is an atypical RIIα-specific A-kinase anchoring protein.

Authors:  Jennifer S Hermann; Philipp Skroblin; Daniela Bertinetti; Laura E Hanold; Eva K von der Heide; Eva-Maria Wagener; Hans-Michael Zenn; Enno Klussmann; Eileen J Kennedy; Friedrich W Herberg
Journal:  Biochim Biophys Acta       Date:  2015-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.